Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 7 min 44 sec ago

ONCOLIX, INC. Announces Capital Raise of $4.2 Million

Tue, 01/27/2015 - 15:19
HOUSTON, Jan. 27, 2015 -- (Healthcare Sales & Marketing Network) -- ONCOLIX, INC., announced today that it has completed a Series A round of financing, led by PoC Capital, LLC and Integrium Clinical Research, LLC. Also participating in the finance round ...
Biopharmaceuticals, Oncology, Venture Capital
ONCOLIX , Prolanta, ovarian cancer

Spectranetics Completes Acquisition of Stellarex(TM) Drug Coated Balloon Assets From Covidien

Tue, 01/27/2015 - 14:48
COLORADO SPRINGS, Colo., Jan. 27, 2015 -- (Healthcare Sales & Marketing Network) -- The Spectranetics Corporation (SPNC) today announced it has completed the acquisition of Covidien's Stellarex(TM) drug coated balloon angioplasty (DCB) platform. The transa...
Devices, Interventional, Acquisitions
Spectranetics, Covidien, Stellarex, drug coated balloon

Euclises Announces Appointment of Bobby Sandage as New CEO

Tue, 01/27/2015 - 14:28
Development Experience to Drive Entry of Novel COX-2 Inhibitors into Clinical Trials for Cancer ST. LOUIS--(Healthcare Sales & Marketing Network)--Euclises Pharmaceuticals, Inc., a biotechnology company developing novel cyclooxygenase-2 (COX-2) inhibito...
Biopharmaceuticals, Oncology, Personnel
Euclises Pharmaceuticals, COX-2 inhibitors, PGE2

FDA Approves Dexcom G4 Platinum Continuous Glucose Monitoring System with Share

Mon, 01/26/2015 - 18:24
Now people with diabetes as young as 2 years of age can automatically and securely share real-time CGM data from their Dexcom receiver to a caregiver’s mobile app SAN DIEGO--(Healthcare Sales & Marketing Network)--DexCom, Inc., (DXCM), a leader in conti...
Devices, Monitoring, Endocrinology, FDA
DexCom, continuous glucose monitor, G4 PLATINUM

Roche receives FDA clearance for next generation cobas MRSA/SA Test

Mon, 01/26/2015 - 18:11
New test detects MRSA and SA, the leading causes of healthcare-associated infections worldwide PLEASANTON, Calif., Jan. 26, 2015 -- (Healthcare Sales & Marketing Network) -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug A...
Diagnostics, FDA
Roche, cobas MRSA/SA Test, MRSA, cobas 4800 System

Regeneron and Sanofi Announce Praluent(TM) (alirocumab) Biologics License Application has Been Accepted for Priority Review by US FDA

Mon, 01/26/2015 - 18:00
TARRYTOWN, N.Y. and PARIS, Jan. 26, 2015 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review the Biologics...
Biopharmaceuticals, FDA
Regeneron Pharmaceuticals, Sanofi, Praluent, alirocumab, hypercholesterolemia

Maquet Medical Systems USA Announces Exclusive US Distribution Agreement with ClearFlow for PleuraFlow(R) Active Clearance Technology(R) System

Fri, 01/23/2015 - 13:27
WAYNE, N.J., Jan. 23, 2015 -- (Healthcare Sales & Marketing Network) -- Maquet Medical Systems USA announced today an exclusive US distribution agreement with ClearFlow, Inc. for its innovative PleuraFlow® Active Clearance Technology® (ACT™) Syste...
Devices, Distribution
Maquet Medical Systems, ClearFlow, PleuraFlow, chest drainage tube

The Medicines Company Receives CHMP Positive Opinions for Three Hospital Acute Care Products: KENGREXAL(TM) (cangrelor), ORBACTIV(TM) (oritavancin) and RAPLIXA(TM) (sealant powder)

Fri, 01/23/2015 - 13:18
CHMP Recommendations for Approval Represent Industry Firsts Across Three Therapeutic Categories PARSIPPANY, N.J.--(Healthcare Sales & Marketing Network)--The Medicines Company today announced that the Committee for Medicinal Products for Human Use (CHMP...
Biopharmaceuticals, Regulatory
The Medicines Company, KENGREXAL, ORBACTIV, RAPLIXA

Aurora Spine Announces First TiNANO(R) Coated Interbody Cage Surgery in Israel

Fri, 01/23/2015 - 13:10
CARLSBAD, CALIFORNIA--(Healthcare Sales & Marketing Network) - Aurora Spine Corporation (TSX VENTURE:ASG) announced today the first surgery in Nazareth, Israel using the EOS™ minimally invasive TLIF Interbody Fusion System featuring TiNano®. The surger...
Devices, Orthopaedic, Neurosurgery
Aurora Spine, TiNano, Interbody Fusion, interbody cage, spine surgery

Elekta plans to introduce MRI-guided radiation therapy system in 2017

Thu, 01/22/2015 - 12:45
"Game-changing" technology discussed at University Medical Center Utrecht UTRECHT, the Netherlands, Jan. 22, 2015 -- (Healthcare Sales & Marketing Network) -- Elekta (EKTA-B.ST) updated the market this morning on its latest research and devel...
Devices, Radiology, Oncology
Elekta, MRI-guided radiation therapy, radiotherapy

Summit Medical, Inc. Obtains Two More FDA Clearances in a Continuing Effort to Accommodate Customers

Wed, 01/21/2015 - 18:26
ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--As technology advances, so does the complexity of medical devices, increasing the difficulty associated with sterilization procedures. Understanding the varying needs of the end user is something tha...
Devices, Surgery, FDA
Summit Medical, InstruSafe, STERRAD

Integra LifeSciences Launches Integra(R) Reinforcement Matrix

Wed, 01/21/2015 - 18:21
Designed for Use During Tendon Healing PLAINSBORO, N.J., Jan. 21, 2015 -- (Healthcare Sales & Marketing Network) -- Integra LifeSciences Holdings Corporation (IART) today announced the full market release of Integra(R) Reinforcement Matrix, a biological...
Devices, Orthopaedic, Product Launch
Integra LifeSciences, Reinforcement Matrix, Stellen Medical

Cohera Medical, Inc.(R) Enters Agreement with B. Braun Surgical, S.A. for Distribution of TissuGlu(R) Surgical Adhesive in Select European Countries

Wed, 01/21/2015 - 18:11
PITTSBURGH, Jan. 21, 2015 -- (Healthcare Sales & Marketing Network) -- Cohera Medical, Inc.®, a leading innovator and developer of absorbable surgical adhesives and sealants, announced today that it has entered into an exclusive sales and marketing di...
Devices, Surgery, Distribution
Cohera Medical, B. Braun, TissuGlu, Surgical Adhesive

Medivir Makes Change within the Management Team

Wed, 01/21/2015 - 16:41
STOCKHOLM--(Healthcare Sales & Marketing Network)--Medivir AB (OMX:MVIR) (STO:MVIRB) announces a reorganization of the management team in order to streamline and increase operational focus. After the change the company´s management team consists of 6...
Biopharmaceuticals, Personnel
Medivir AB

NovaBay Expands Sales Force for Avenova

Tue, 01/20/2015 - 13:27
35-person sales team to market NovaBay’s breakthrough Avenova product to ophthalmologists and optometrists in every major U.S. market NovaBay management and key industry opinion leaders to hold an investment community conference call tomorrow, January ...
Biopharmaceuticals, Ophthalmology
NovaBay Pharmaceuticals, Avenova, blepharitis

Akers Expands U.S. Sales Efforts With Key Leadership Additions

Tue, 01/20/2015 - 13:21
THOROFARE, N.J., Jan. 20, 2015 -- (Healthcare Sales & Marketing Network) -- Akers Biosciences, Inc. (AKER) (AIM:AKR.L), (the "Company"), a leading designer and manufacturer of rapid diagnostic screening and testing products, announces the recruit...
Diagnostics, Personnel
Akers Biosciences

Gecko Biomedical Receives 1.3 Million Euros From Bpifrance to Advance its Bio-Inspired Surgical Adhesive Solutions

Tue, 01/20/2015 - 13:14
PARIS, January 20, 2015 -- (Healthcare Sales & Marketing Network) -- Gecko Biomedical, a French medical device company developing 'bio-inspired' biodegradable surgical glues and patches for wound closure, announces today it has received 1.3 million euros ...
Devices, Surgery, Venture Capital
Gecko Biomedical, surgical adhesive, surgical glue

CytRx Announces FDA's Removal of Partial Clinical Hold for Aldoxorubicin Clinical Trials Permitting Immediate Enrollment of New Patients

Tue, 01/20/2015 - 13:07
Company does not expect estimated timelines to materially change LOS ANGELES, Jan. 20, 2015 -- (Healthcare Sales & Marketing Network) -- CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, today anno...
Biopharmaceuticals, Oncology, FDA
CytRx, aldoxorubicin

ECA Medical Instruments Develops First Disposable Spinal Instrument Fixation Kit to Gain FDA Approval with Intelligent Implant Systems

Fri, 01/16/2015 - 13:21
Intelligent Implant Systems Revolution Spinal System™ features ECA’s sterile packed, disposable instrument set to ease workflow, save cost and boost OR efficiency in inpatient and outpatient settings. THOUSAND OAKS, Calif.--(Healthcare Sales & Marketing...
Devices, Orthopaedic, Neurosurgery, FDA
ECA Medical Instruments, Revolution Spinal System, spine surgery

European Commission Grants Marketing Authorizations for AbbVie's VIEKIRAX(R) (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA(R) (dasabuvir tablets) for the Treatment of Chronic Hepatitis C

Fri, 01/16/2015 - 13:09
In Phase 3 clinical trials, VIEKIRAX + EXVIERA cured 95-100 percent of genotype 1 chronic hepatitis C patients, with less than 2 percent of patients experiencing virologic failure[1],[2] Tolerability profile shows more than 98 percent of patients comple...
Biopharmaceuticals, Regulatory
AbbVie , VIEKIRAX, EXVIERA, hepatitis C

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong